SWOG clinical trial number
SWOG-7806
Cis-Diamminedichloroplatinum (II) in the Treatment of Refractory Epidermoid Carcinoma of the Esophagus
Closed
Abbreviated Title
Cis-Diamminedichloroplatinum (II) in the Treatment of Refractory Epidermoid Carcinoma of the Esophagus
Activated
03/29/1978
Closed
01/29/1981
Publication Information Expand/Collapse
1984
Chemotherapy of advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: Final report on a Southwest Oncology Group study.
1981
Cis-diamminedichloride platinum (II), an effective agent in the treatment of epidermoid carcinoma of the esophagus. A preliminary report of an ongoing Southwest Oncology Group study.
Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.
Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.
Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.